LAVA THERAPEUTICS N.V.
11.20%
2,947,781
1840748
N51517105
Oct 14, 2025
Oct 17, 2025, 06:01 PM
Reporting Persons (5)
This is a joint filing. The reported shares may overlap between reporting persons and should not be summed.
| Name | Type | % of Class | Aggregate | Sole Voting | Shared Voting |
|---|---|---|---|---|---|
| Cooperatieve Gilde Healthcare IV U.A. | Other | 11.20% | 2,947,781 | 0 | 2,947,781 |
| Gilde Healthcare IV Management B.V. | Other | 11.20% | 2,947,781 | 0 | 2,947,781 |
| Gilde Healthcare Holding B.V. | Other | 11.20% | 2,947,781 | 0 | 2,947,781 |
| Manapouri B.V. | Other | 11.20% | 2,947,781 | 0 | 2,947,781 |
| Martemanshurk B.V. | Other | 11.20% | 2,947,781 | 0 | 2,947,781 |
Disclosure Items (3)
Common shares, Euro 0.12 nominal value per share
LAVA THERAPEUTICS N.V.
Yalelaan 62, Utrecht, P7, 3584 CM
According to the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission ("SEC") on August 13, 2025, there were 26,305,295 Common Shares outstanding as of August 8, 2025. Gilde Healthcare is the record holder of an aggregate of 2,947,781 Common Shares, which represents beneficial ownership of approximately 11.2% of the outstanding Common Shares as of August 8, 2025. GHCIVM, as the manager of Gilde Healthcare, has the power to vote and dispose of securities held by Gilde Healthcare and may be deemed to beneficially own the securities held of record by Gilde Healthcare. As a result, each of the Reporting Persons may beneficially own 2,947,781 Common Shares, or approximately 11.2% of the outstanding Common Shares.
Each Reporting Person has shared power to vote and dispose of 2,947,781 Common Shares.
On October 14, 2025, Gilde Healthcare sold 227,341 Common Shares at a weighted average price per share of $1.5092 for aggregate proceeds of approximately $343,103.04. On October 15, 2025, Gilde Healthcare sold 200,000 Common Shares at a weighted average price per share of $1.5070 for aggregate proceeds of approximately $301,400.89. On October 16, 2025, Gilde Healthcare sold 690,239 Common Shares at a weighted average price per share of $1.4936 for aggregate proceeds of approximately $1,030,940.97. On October 17, 2025, Gilde Healthcare sold 1,181,131 Common Shares at a weighted average price per share of $1.4743 for aggregate proceeds of approximately $1,741,341.43.